Mark E. Jones

Characterization of <i>grlA</i> , <i>grlB</i> , <i>gyrA</i> , and <i>gyrB</i> Mutations in 116 Unrelated Isolates of <i>Staphylococcus aureus</i> and Effects of Mutations on Ciprofloxacin MIC

Franz‐Josef Schmitz, Mark E. Jones, B. Hofmann et al. · Antimicrobial Agents and Chemotherapy · 1998 · 130 citations · Full text

Life Sciences, Genetics, Microbiology +17

Toxin Involvement in Staphylococcal Scalded Skin Syndrome

Gérard Lina, Yves Gillet, François Vandenesch et al. · Clinical Infectious Diseases · 1997 · 107 citations · Full text

Life Sciences, Dermatology, Infectious Diseases +17

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997

Ad C. Fluit, Mark E. Jones, F.-J. Schmitz et al. · Antonie van Leeuwenhoek · 2000 · 74 citations

Life Sciences, Infectious Diseases, Microbiology +16

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

Mark E. Jones, Deborah C. Draghi, James A. Karlowsky et al. · Annals of Clinical Microbiology and Antimicrobials · 2004 · 54 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment

Mark E. Jones, Nienke M. Boenink, J. Verhoef et al. · Journal of Antimicrobial Chemotherapy · 2000 · 48 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17